このアイテムのアクセス数: 131

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41467-023-42639-y.pdf1.03 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorOta, Kenjien
dc.contributor.authorNagao, Kazunorien
dc.contributor.authorHata, Daien
dc.contributor.authorSugiyama, Harukien
dc.contributor.authorSegawa, Yasutomoen
dc.contributor.authorTokunoh, Ryosukeen
dc.contributor.authorSeki, Tomohiroen
dc.contributor.authorMiyamoto, Naoyaen
dc.contributor.authorSasaki, Yusukeen
dc.contributor.authorOhmiya, Hirohisaen
dc.contributor.alternative太田, 健治ja
dc.contributor.alternative長尾, 一哲ja
dc.contributor.alternative秦, 大ja
dc.contributor.alternative杉山, 晴紀ja
dc.contributor.alternative瀬川, 泰知ja
dc.contributor.alternative得能, 僚資ja
dc.contributor.alternative関, 倫宏ja
dc.contributor.alternative宮本, 尚也ja
dc.contributor.alternative佐々木, 悠祐ja
dc.contributor.alternative大宮, 寛久ja
dc.date.accessioned2023-11-02T00:38:48Z-
dc.date.available2023-11-02T00:38:48Z-
dc.date.issued2023-10-31-
dc.identifier.urihttp://hdl.handle.net/2433/285976-
dc.description光エネルギーで新しい化学修飾核酸を合成 --核酸リン原子の第三級アルキル化に成功--. 京都大学プレスリリース. 2023-11-01.ja
dc.description.abstractChemical modification of nucleotides can improve the metabolic stability and target specificity of oligonucleotide therapeutics, and alkylphosphonates have been employed as charge-neutral replacements for naturally-occurring phosphodiester backbones in these compounds. However, at present, the alkyl moieties that can be attached to phosphorus atoms in these compounds are limited to methyl groups or primary/secondary alkyls, and such alkylphosphonate moieties can degrade during oligonucleotide synthesis. The present work demonstrates the tertiary alkylation of the phosphorus atoms of phosphites bearing two 2’-deoxynuclosides. This process utilizes a carbocation generated via a light-driven radical-polar crossover mechanism. This protocol provides tertiary alkylphosphonate structures that are difficult to synthesize using existing methods. The conversion of these species to oligonucleotides having charge-neutral alkylphosphonate linkages through a phosphoramidite-based approach was also confirmed in this study.en
dc.language.isoeng-
dc.publisherSpringer Natureen
dc.rights© The Author(s) 2023en
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/-
dc.subjectSynthetic chemistry methodologyen
dc.subjectNatural product synthesisen
dc.subjectReaction mechanismsen
dc.titleSynthesis of tertiary alkylphosphonate oligonucleotides through light-driven radical-polar crossover reactionsen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleNature Communicationsen
dc.identifier.volume14-
dc.relation.doi10.1038/s41467-023-42639-y-
dc.textversionpublisher-
dc.identifier.artnum6856-
dc.addressInstitute for Chemical Research, Kyoto Universityen
dc.addressInstitute for Chemical Research, Kyoto Universityen
dc.addressResearch, Takeda Pharmaceutical Company Limiteden
dc.addressInstitute for Molecular Science; Comprehensive Research Organization for Science and Society Neutron Industrial Application Promotion Center; Graduate Institute for Advanced Studies, SOKENDAIen
dc.addressInstitute for Molecular Science; Graduate Institute for Advanced Studies, SOKENDAIen
dc.addressResearch, Takeda Pharmaceutical Company Limiteden
dc.addressResearch, Takeda Pharmaceutical Company Limiteden
dc.addressResearch, Takeda Pharmaceutical Company Limiteden
dc.addressResearch, Takeda Pharmaceutical Company Limiteden
dc.addressInstitute for Chemical Research, Kyoto University; JST, PRESTOen
dc.identifier.pmid37907473-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2023-11-01-
dcterms.accessRightsopen access-
datacite.awardNumber21H04681-
datacite.awardNumber23H04912-
datacite.awardNumber22KJ1938-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H04681/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PLANNED-23H04912/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22KJ1938/-
dc.identifier.eissn2041-1723-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitleラジカルが拓く有機触媒化学ja
jpcoar.awardTitle光エネルギーを利用した複雑かつ嵩高い分子の自在変換ja
jpcoar.awardTitleラジカル-ラジカルカップリングを活用した核酸誘導体の化学修飾ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons